1995, 2nd ed., ISBN 9780781701884, xi, 219
Book
1989, ISBN 0812112601, 129
Book
Nuclear Medicine Communications, ISSN 0143-3636, 11/2010, Volume 31, Issue 11, pp. 952 - 957
PURPOSEThe participation in concussive susceptible sports such as boxing may cause chronic traumatic brain injury. The objective of this study was to determine...
boxers | chronic traumatic brain injury | positron emission tomography | statistical parametric mapping | CEREBRAL GLUCOSE-METABOLISM | MRI | PROFESSIONAL BOXERS | RISK | DIFFUSION | SIGN | DEFICITS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
boxers | chronic traumatic brain injury | positron emission tomography | statistical parametric mapping | CEREBRAL GLUCOSE-METABOLISM | MRI | PROFESSIONAL BOXERS | RISK | DIFFUSION | SIGN | DEFICITS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 09/2015, Volume 9, pp. 5215 - 5223
Journal Article
Biological Psychiatry, ISSN 0006-3223, 12/2005, Volume 58, Issue 12, pp. 947 - 954
Background: The anxious phenotype of the 5-HT receptor knockout mouse and the anxiolytic properties of 5-HT agonists suggest that the 5-HT receptor modulates...
Hypochondriacal | Panic | Psychic | Somatic | Serotonin | Depression | 5-HT | Pyridines | Piperazines | Depressive Disorder, Major - metabolism | Humans | Middle Aged | Anxiety - psychology | Male | Panic Disorder - diagnostic imaging | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Panic Disorder - metabolism | Brain Chemistry - physiology | Hippocampus - metabolism | Psychiatric Status Rating Scales | Image Processing, Computer-Assisted | Anxiety - diagnostic imaging | Prefrontal Cortex - metabolism | Serotonin Antagonists | Adult | Female | Aged | Anxiety - metabolism | Principal Component Analysis | Receptor, Serotonin, 5-HT1A - metabolism
Hypochondriacal | Panic | Psychic | Somatic | Serotonin | Depression | 5-HT | Pyridines | Piperazines | Depressive Disorder, Major - metabolism | Humans | Middle Aged | Anxiety - psychology | Male | Panic Disorder - diagnostic imaging | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Panic Disorder - metabolism | Brain Chemistry - physiology | Hippocampus - metabolism | Psychiatric Status Rating Scales | Image Processing, Computer-Assisted | Anxiety - diagnostic imaging | Prefrontal Cortex - metabolism | Serotonin Antagonists | Adult | Female | Aged | Anxiety - metabolism | Principal Component Analysis | Receptor, Serotonin, 5-HT1A - metabolism
Journal Article
Journal of Nuclear Medicine Technology, ISSN 0091-4916, 09/2009, Volume 37, Issue 3, pp. 191 - 195
Journal Article
04/2013, ISBN 9781451153392
Book
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 07/2000, Volume 97, Issue 14, pp. 8104 - 8109
The classical dopamine hypothesis of schizophrenia postulates a hyperactivity of dopaminergic transmission at the D 2 receptor. We measured in vivo occupancy...
Predictive Value of Tests | Recurrence | Schizophrenia - metabolism | Humans | Tyrosine 3-Monooxygenase - antagonists & inhibitors | Male | Receptors, Dopamine D2 - metabolism | Corpus Striatum - metabolism | Antipsychotic Agents - therapeutic use | Adult | Female | Schizophrenia - drug therapy | alpha-Methyltyrosine - pharmacology | Chronic Disease | Dopamine - metabolism | Biological Sciences
Predictive Value of Tests | Recurrence | Schizophrenia - metabolism | Humans | Tyrosine 3-Monooxygenase - antagonists & inhibitors | Male | Receptors, Dopamine D2 - metabolism | Corpus Striatum - metabolism | Antipsychotic Agents - therapeutic use | Adult | Female | Schizophrenia - drug therapy | alpha-Methyltyrosine - pharmacology | Chronic Disease | Dopamine - metabolism | Biological Sciences
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2006, Volume 59, Issue 2, pp. 106 - 113
Serotonin 1A receptors (5-HT ) are implicated in the pathophysiology of major depressive disorder (MDD) and in the action of selective serotonin reuptake...
Unipolar | polymorphism | medication | antidepressants | genotype | Medication | Genotype | Antidepressants | Polymorphism | ANTIDEPRESSANT-TREATMENT | HEALTHY-SUBJECTS | PSYCHIATRY | unipolar | CEREBROSPINAL-FLUID | SUICIDE VICTIMS | POSTSYNAPTIC 5-HT1A | NEUROSCIENCES | 1(A) RECEPTOR | 5-HT1A RECEPTOR-BINDING | BIPOLAR DEPRESSION | MONOAMINE METABOLITES | RAT-BRAIN | Depressive Disorder, Major - metabolism | Humans | Receptor, Serotonin, 5-HT1A - genetics | Male | Piperazines - metabolism | Reference Values | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Promoter Regions, Genetic - genetics | Polymorphism, Genetic | Antidepressive Agents - therapeutic use | Receptor, Serotonin, 5-HT1A - drug effects | Pyridines - metabolism | Depressive Disorder, Major - genetics | Adolescent | Adult | Female | Serotonin Antagonists - metabolism | Carbon Radioisotopes - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Depressive Disorder, Major - drug therapy | Phenols | Serotonin uptake inhibitors | PET imaging | Serotonin | Medical societies | Major depressive disorder
Unipolar | polymorphism | medication | antidepressants | genotype | Medication | Genotype | Antidepressants | Polymorphism | ANTIDEPRESSANT-TREATMENT | HEALTHY-SUBJECTS | PSYCHIATRY | unipolar | CEREBROSPINAL-FLUID | SUICIDE VICTIMS | POSTSYNAPTIC 5-HT1A | NEUROSCIENCES | 1(A) RECEPTOR | 5-HT1A RECEPTOR-BINDING | BIPOLAR DEPRESSION | MONOAMINE METABOLITES | RAT-BRAIN | Depressive Disorder, Major - metabolism | Humans | Receptor, Serotonin, 5-HT1A - genetics | Male | Piperazines - metabolism | Reference Values | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Promoter Regions, Genetic - genetics | Polymorphism, Genetic | Antidepressive Agents - therapeutic use | Receptor, Serotonin, 5-HT1A - drug effects | Pyridines - metabolism | Depressive Disorder, Major - genetics | Adolescent | Adult | Female | Serotonin Antagonists - metabolism | Carbon Radioisotopes - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Depressive Disorder, Major - drug therapy | Phenols | Serotonin uptake inhibitors | PET imaging | Serotonin | Medical societies | Major depressive disorder
Journal Article
Seminars in Nuclear Medicine, ISSN 0001-2998, 2009, Volume 39, Issue 3, pp. 195 - 203
Interventional nuclear brain imaging incorporates a variety of radiopharmaceutical techniques to enhance the functional assessment of the central nervous...
Radiology | OBSTRUCTIVE SLEEP-APNEA | STRIATAL DOPAMINE RELEASE | ADVANCED PARKINSONS-DISEASE | GLUCOSE-METABOLISM | TEMPORARY BALLOON OCCLUSION | REUPTAKE INHIBITOR CITALOPRAM | CEREBRAL-BLOOD-FLOW | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | EMISSION COMPUTED-TOMOGRAPHY | INTERNAL CAROTID-ARTERY | SEROTONIN TRANSPORTERS | Brain - diagnostic imaging | Parkinson Disease - diagnostic imaging | Cerebrovascular Circulation - physiology | Receptors, Opioid, mu - metabolism | Humans | Middle Aged | Brain Mapping - methods | Positron-Emission Tomography - methods | Seizures - diagnostic imaging | Balloon Occlusion - methods | Brain - blood supply | Serotonin - metabolism | Adult | Female | Sleep Apnea, Obstructive - diagnostic imaging | Aged | Alzheimer Disease - diagnostic imaging | Radiopharmaceuticals | Dopamine - metabolism
Radiology | OBSTRUCTIVE SLEEP-APNEA | STRIATAL DOPAMINE RELEASE | ADVANCED PARKINSONS-DISEASE | GLUCOSE-METABOLISM | TEMPORARY BALLOON OCCLUSION | REUPTAKE INHIBITOR CITALOPRAM | CEREBRAL-BLOOD-FLOW | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | EMISSION COMPUTED-TOMOGRAPHY | INTERNAL CAROTID-ARTERY | SEROTONIN TRANSPORTERS | Brain - diagnostic imaging | Parkinson Disease - diagnostic imaging | Cerebrovascular Circulation - physiology | Receptors, Opioid, mu - metabolism | Humans | Middle Aged | Brain Mapping - methods | Positron-Emission Tomography - methods | Seizures - diagnostic imaging | Balloon Occlusion - methods | Brain - blood supply | Serotonin - metabolism | Adult | Female | Sleep Apnea, Obstructive - diagnostic imaging | Aged | Alzheimer Disease - diagnostic imaging | Radiopharmaceuticals | Dopamine - metabolism
Journal Article
DRUG DESIGN DEVELOPMENT AND THERAPY, ISSN 1177-8881, 2015, Volume 9, Issue default, pp. 5215 - 5223
In the era of personalized medicine, diagnostic approaches are helping pharmaceutical and biotechnology sponsors streamline the clinical trial process....
oncology trials | ESTROGEN-RECEPTORS | CHEMISTRY, MEDICINAL | RESPONSE CRITERIA | SOLID TUMORS | GUIDELINES | molecular imaging | personalized medicine | INTERNATIONAL WORKING GROUP | BREAST-CANCER | diagnostic assays | RECOMMENDATIONS | PHARMACOLOGY & PHARMACY | companion diagnostics | CARCINOMA | PET | Radiopharmaceuticals - administration & dosage | Medical Oncology - methods | Molecular Diagnostic Techniques | Humans | Neoplasms - diagnosis | Clinical Trials as Topic - methods | Precision Medicine - methods | Clinical trials | Usage | Diagnostic imaging | Biological assay | Innovations | Drugs | Biotechnology | Regulatory agencies | Nuclear magnetic resonance--NMR | Target recognition | Lung cancer | Medical services | Oncology | Drug development | Cancer therapies | Epidermal growth factor | Precision medicine | Vitamin B | Food | Medical research | Modernization | Medical imaging | Biological products | Medical treatment | Breast cancer | FDA approval | Patients | Diagnostic software | Biomarkers | Critical path | Diagnostic systems | Commercialization | Cancer
oncology trials | ESTROGEN-RECEPTORS | CHEMISTRY, MEDICINAL | RESPONSE CRITERIA | SOLID TUMORS | GUIDELINES | molecular imaging | personalized medicine | INTERNATIONAL WORKING GROUP | BREAST-CANCER | diagnostic assays | RECOMMENDATIONS | PHARMACOLOGY & PHARMACY | companion diagnostics | CARCINOMA | PET | Radiopharmaceuticals - administration & dosage | Medical Oncology - methods | Molecular Diagnostic Techniques | Humans | Neoplasms - diagnosis | Clinical Trials as Topic - methods | Precision Medicine - methods | Clinical trials | Usage | Diagnostic imaging | Biological assay | Innovations | Drugs | Biotechnology | Regulatory agencies | Nuclear magnetic resonance--NMR | Target recognition | Lung cancer | Medical services | Oncology | Drug development | Cancer therapies | Epidermal growth factor | Precision medicine | Vitamin B | Food | Medical research | Modernization | Medical imaging | Biological products | Medical treatment | Breast cancer | FDA approval | Patients | Diagnostic software | Biomarkers | Critical path | Diagnostic systems | Commercialization | Cancer
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 01/2006, Volume 163, Issue 1, pp. 48 - 51
OBJECTIVE: The authors examined effects of a triallelic functional polymorphism of the human serotonin-transporter-linked promoter region (5-HTTLPR) on in vivo...
SYSTEM | GENE | 5-HTTLPR | GENOTYPE | AVAILABILITY | PSYCHIATRY | ALLELIC VARIANTS | SUICIDAL-BEHAVIOR | MAJOR DEPRESSION | BINDING | SPECT | Brain - diagnostic imaging | Gene Expression | Age Factors | Isoquinolines | Depressive Disorder, Major - metabolism | Gene Frequency | Humans | Genotype | Male | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Promoter Regions, Genetic - genetics | Polymorphism, Genetic | Brain - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Phenotype | Serotonin Plasma Membrane Transport Proteins - genetics | Depressive Disorder, Major - genetics | Alleles | Adult | Female | Carbon Radioisotopes | Research | Serotonin | Neurological research | Depression, Mental | Psychiatric research
SYSTEM | GENE | 5-HTTLPR | GENOTYPE | AVAILABILITY | PSYCHIATRY | ALLELIC VARIANTS | SUICIDAL-BEHAVIOR | MAJOR DEPRESSION | BINDING | SPECT | Brain - diagnostic imaging | Gene Expression | Age Factors | Isoquinolines | Depressive Disorder, Major - metabolism | Gene Frequency | Humans | Genotype | Male | Positron-Emission Tomography | Depressive Disorder, Major - diagnostic imaging | Promoter Regions, Genetic - genetics | Polymorphism, Genetic | Brain - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Phenotype | Serotonin Plasma Membrane Transport Proteins - genetics | Depressive Disorder, Major - genetics | Alleles | Adult | Female | Carbon Radioisotopes | Research | Serotonin | Neurological research | Depression, Mental | Psychiatric research
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 01/2006, Volume 163, Issue 1, pp. 52 - 58
OBJECTIVE: CSF analysis, neuroendocrine challenges, serotonin depletion studies, and treatment studies implicate the serotonergic system in the pathophysiology...
DENSITY | GRAPHICAL ANALYSIS | MOOD DISORDERS | ABNORMALITIES | PSYCHIATRY | ELIMINATION | SUICIDE VICTIMS | EXPRESSION | PREFRONTAL CORTEX | PET | AMYGDALA | Brain - diagnostic imaging | Isoquinolines | Mesencephalon - metabolism | Depressive Disorder, Major - metabolism | Humans | Suicide, Attempted - statistics & numerical data | Male | Brain - metabolism | Psychiatric Status Rating Scales | Adult | Female | Severity of Illness Index | Amygdala - diagnostic imaging | Amygdala - metabolism | Hospitalization | Depressive Disorder, Major - diagnostic imaging | Ambulatory Care | Antidepressive Agents - therapeutic use | Serotonin Plasma Membrane Transport Proteins - metabolism | Suicide, Attempted - psychology | Mesencephalon - diagnostic imaging | Positron-Emission Tomography - statistics & numerical data | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Carbon Radioisotopes | Research | Serotonin | Neurological research | Depression, Mental | Psychiatric research
DENSITY | GRAPHICAL ANALYSIS | MOOD DISORDERS | ABNORMALITIES | PSYCHIATRY | ELIMINATION | SUICIDE VICTIMS | EXPRESSION | PREFRONTAL CORTEX | PET | AMYGDALA | Brain - diagnostic imaging | Isoquinolines | Mesencephalon - metabolism | Depressive Disorder, Major - metabolism | Humans | Suicide, Attempted - statistics & numerical data | Male | Brain - metabolism | Psychiatric Status Rating Scales | Adult | Female | Severity of Illness Index | Amygdala - diagnostic imaging | Amygdala - metabolism | Hospitalization | Depressive Disorder, Major - diagnostic imaging | Ambulatory Care | Antidepressive Agents - therapeutic use | Serotonin Plasma Membrane Transport Proteins - metabolism | Suicide, Attempted - psychology | Mesencephalon - diagnostic imaging | Positron-Emission Tomography - statistics & numerical data | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Carbon Radioisotopes | Research | Serotonin | Neurological research | Depression, Mental | Psychiatric research
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 06/2017, Volume 11, pp. 1719 - 1728
An operationalized workflow paradigm is presented and validated with pilot subject data. This approach is reproducible with a high concordance rate between...
Molecular imaging | Lymphoma | Oncology trials | Lugano criteria | oncology trials | B-CELL LYMPHOMA | CHEMISTRY, MEDICINAL | INTERNATIONAL WORKSHOP | THERAPY | RESPONSE CRITERIA | lymphoma | CLASSIFICATION | PHARMACOLOGY & PHARMACY | SCAN | molecular imaging | Reproducibility of Results | Lymphoma - diagnostic imaging | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Molecular Imaging | Workflow | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Clinical Trials as Topic - standards | Neoplasm Staging | Research Design | Observer Variation | Cohort Studies | Positron Emission Tomography Computed Tomography - standards | CT imaging | Usage | Care and treatment | Lymphomas | Diagnosis | PET imaging | Confidence intervals | Medical research | Clinical trials | Lesions | Medical imaging | Transplants & implants | Disease | Working groups | Oncology | Bone marrow | Blood diseases | Cancer
Molecular imaging | Lymphoma | Oncology trials | Lugano criteria | oncology trials | B-CELL LYMPHOMA | CHEMISTRY, MEDICINAL | INTERNATIONAL WORKSHOP | THERAPY | RESPONSE CRITERIA | lymphoma | CLASSIFICATION | PHARMACOLOGY & PHARMACY | SCAN | molecular imaging | Reproducibility of Results | Lymphoma - diagnostic imaging | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Molecular Imaging | Workflow | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Clinical Trials as Topic - standards | Neoplasm Staging | Research Design | Observer Variation | Cohort Studies | Positron Emission Tomography Computed Tomography - standards | CT imaging | Usage | Care and treatment | Lymphomas | Diagnosis | PET imaging | Confidence intervals | Medical research | Clinical trials | Lesions | Medical imaging | Transplants & implants | Disease | Working groups | Oncology | Bone marrow | Blood diseases | Cancer
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2000, Volume 48, Issue 7, pp. 627 - 640
Background: Recent brain imaging studies have indicated that schizophrenia is associated with increased amphetamine-induced dopamine release in the striatum....
[ 123I]IBZM | ketamine | Schizophrenia | amphetamine | dopamine | SPECT | glutamate | I]IBZM | Amphetamine | Dopamine | Ketamine | Glutamate | IN-VIVO MICRODIALYSIS | NONCOMPETITIVE NMDA ANTAGONIST | PSYCHIATRY | schizophrenia | [I-123]IBZM | EMISSION-TOMOGRAPHY PET | NEUROSCIENCES | DUAL-PROBE MICRODIALYSIS | VENTRAL TEGMENTAL AREA | RAT SUBSTANTIA-NIGRA | CEREBRAL BLOOD-FLOW | ACID RECEPTOR SUBTYPES | MEDIAL PREFRONTAL CORTEX | METHYL-D-ASPARTATE | Receptors, N-Methyl-D-Aspartate - drug effects | Synaptic Transmission - physiology | Corpus Striatum - physiopathology | Humans | Prefrontal Cortex - physiopathology | Amphetamine - pharmacology | Tomography, Emission-Computed, Single-Photon | Male | Excitatory Amino Acid Antagonists - pharmacology | Receptors, N-Methyl-D-Aspartate - physiology | Prefrontal Cortex - drug effects | Dopamine Agents - pharmacology | Schizophrenia - physiopathology | Corpus Striatum - drug effects | Pyrrolidines | Adult | Female | Synaptic Transmission - drug effects | Benzamides | Ketamine - pharmacology | Dopamine Antagonists | Dopamine - metabolism
[ 123I]IBZM | ketamine | Schizophrenia | amphetamine | dopamine | SPECT | glutamate | I]IBZM | Amphetamine | Dopamine | Ketamine | Glutamate | IN-VIVO MICRODIALYSIS | NONCOMPETITIVE NMDA ANTAGONIST | PSYCHIATRY | schizophrenia | [I-123]IBZM | EMISSION-TOMOGRAPHY PET | NEUROSCIENCES | DUAL-PROBE MICRODIALYSIS | VENTRAL TEGMENTAL AREA | RAT SUBSTANTIA-NIGRA | CEREBRAL BLOOD-FLOW | ACID RECEPTOR SUBTYPES | MEDIAL PREFRONTAL CORTEX | METHYL-D-ASPARTATE | Receptors, N-Methyl-D-Aspartate - drug effects | Synaptic Transmission - physiology | Corpus Striatum - physiopathology | Humans | Prefrontal Cortex - physiopathology | Amphetamine - pharmacology | Tomography, Emission-Computed, Single-Photon | Male | Excitatory Amino Acid Antagonists - pharmacology | Receptors, N-Methyl-D-Aspartate - physiology | Prefrontal Cortex - drug effects | Dopamine Agents - pharmacology | Schizophrenia - physiopathology | Corpus Striatum - drug effects | Pyrrolidines | Adult | Female | Synaptic Transmission - drug effects | Benzamides | Ketamine - pharmacology | Dopamine Antagonists | Dopamine - metabolism
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 7/2005, Volume 25, Issue 7, pp. 785 - 793
Two measures used in brain imaging are binding potential (BP) and the specific to nonspecific equilibrium partition coefficient (V3“). V3” determined using the...
Brain | Reference tissue | Serotonin | C]WAY-100635 | Modeling | PET | [C-11]WAY-100635 | DEPRESSION | modeling | ANTAGONIST | RADIOLIGAND | reference tissue | H-3 WAY-100635 | MODEL | brain | SUICIDE VICTIMS | NEUROSCIENCES | serotonin | ENDOCRINOLOGY & METABOLISM | SEGMENTATION | BINDING-SITES | HEMATOLOGY | Cerebellum - metabolism | Humans | Male | Piperazines - metabolism | Positron-Emission Tomography | Sex Characteristics | Autoradiography | Magnetic Resonance Imaging | Cerebellum - diagnostic imaging | Pyridines - metabolism | Cerebellum - cytology | Adult | Female | Kinetics | Receptor, Serotonin, 5-HT1A - metabolism
Brain | Reference tissue | Serotonin | C]WAY-100635 | Modeling | PET | [C-11]WAY-100635 | DEPRESSION | modeling | ANTAGONIST | RADIOLIGAND | reference tissue | H-3 WAY-100635 | MODEL | brain | SUICIDE VICTIMS | NEUROSCIENCES | serotonin | ENDOCRINOLOGY & METABOLISM | SEGMENTATION | BINDING-SITES | HEMATOLOGY | Cerebellum - metabolism | Humans | Male | Piperazines - metabolism | Positron-Emission Tomography | Sex Characteristics | Autoradiography | Magnetic Resonance Imaging | Cerebellum - diagnostic imaging | Pyridines - metabolism | Cerebellum - cytology | Adult | Female | Kinetics | Receptor, Serotonin, 5-HT1A - metabolism
Journal Article
Neuroimage, ISSN 1053-8119, 2003, Volume 19, Issue 3, pp. 1215 - 1227
Cognitive reserve (CR) is the ability of an individual to cope with advancing brain pathology so that he remains free of symptomatology. Epidemiological...
FDG-PET | MINI-MENTAL-STATE | ALZHEIMERS-DISEASE | EDUCATION | NEUROSCIENCES | NEUROIMAGING | METABOLIC-RATES | RETRIEVAL | POSITRON-EMISSION-TOMOGRAPHY | AGE-RELATED-CHANGES | CEREBRAL-BLOOD-FLOW | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | WORKING-MEMORY | Studies | Variables | Pathology | Neuropathology | Older people | Memory | Aging | Standard deviation | Age | Dementia
FDG-PET | MINI-MENTAL-STATE | ALZHEIMERS-DISEASE | EDUCATION | NEUROSCIENCES | NEUROIMAGING | METABOLIC-RATES | RETRIEVAL | POSITRON-EMISSION-TOMOGRAPHY | AGE-RELATED-CHANGES | CEREBRAL-BLOOD-FLOW | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | WORKING-MEMORY | Studies | Variables | Pathology | Neuropathology | Older people | Memory | Aging | Standard deviation | Age | Dementia
Journal Article
2010, 4th ed., ISBN 0781788978
Web Resource
2010, 4th ed., ISBN 0781788978
Web Resource